期刊文献+

Experimental Study of Yishou Tiaozhi Tablet(益寿调脂片) on Inhibiting Hyperlipemia and Atherosclerosis

Experimental Study of Yishou Tiaozhi Tablet(益寿调脂片) on Inhibiting Hyperlipemia and Atherosclerosis
原文传递
导出
摘要 Objective: To observe the effect of Yishou Tiaozhi tablet(YSTZT) on lipid metabolism and aortic intimal atherosclerotic plaque coverage in rabbit model of experimental hyperlipemia and atherosclerosis.Methods: Thirty two rabbits were randomly divided into four groups, Group A, B, C and D, 8 in each group. Forage with cholesterol and lipid plus 1.59 g/kg of YSTZT was fed to Group A every day;for Group B, 22.54 mg/kg gypenoside tablet was added to forage with cholesterol and lipid; for Group C, hyperlipid forage was given and for Group D, only ordinary forage was given. Biochemical parameters were measured and pathomorphological examinations were carried out 6 weeks later.Results: (1) YSTZT obviously lowered the levels of serum total cholesterol(TC), triglyceride(TG), atherosclerotic index(AI), apoprotein(ApoB), lipoprotein [Lp(a)], oxygen low density lipoprotein cholesterol(ox LDL), hydroxyproline(HYP), plasma Ca 2+ , thromboxane B 2(TXB 2), and increased the levels of serum high density lipoprotein cholesterol(HDL C), apoprotein A 1(Apo A 1), ApoA 1 /ApoB, plasma 6 keto PGF 1α ( P <0.01). (2) Pathomorphological examination showed that in Group A aortic intimal atherosclerotic plaque area and arterial intima thickness were obviously reduced, smooth muscle cell hyperplasia and elastic fibers were not seen.Conclusion: YSTZT can inhibit experimental hyperlipemia and atherogenesis. It is an ideal and effective medicine in preventing and treating hyperlipemia and atherosclerosis. Objective: To observe the effect of Yishou Tiaozhi tablet(YSTZT) on lipid metabolism and aortic intimal atherosclerotic plaque coverage in rabbit model of experimental hyperlipemia and atherosclerosis.Methods: Thirty two rabbits were randomly divided into four groups, Group A, B, C and D, 8 in each group. Forage with cholesterol and lipid plus 1.59 g/kg of YSTZT was fed to Group A every day;for Group B, 22.54 mg/kg gypenoside tablet was added to forage with cholesterol and lipid; for Group C, hyperlipid forage was given and for Group D, only ordinary forage was given. Biochemical parameters were measured and pathomorphological examinations were carried out 6 weeks later.Results: (1) YSTZT obviously lowered the levels of serum total cholesterol(TC), triglyceride(TG), atherosclerotic index(AI), apoprotein(ApoB), lipoprotein [Lp(a)], oxygen low density lipoprotein cholesterol(ox LDL), hydroxyproline(HYP), plasma Ca 2+ , thromboxane B 2(TXB 2), and increased the levels of serum high density lipoprotein cholesterol(HDL C), apoprotein A 1(Apo A 1), ApoA 1 /ApoB, plasma 6 keto PGF 1α ( P <0.01). (2) Pathomorphological examination showed that in Group A aortic intimal atherosclerotic plaque area and arterial intima thickness were obviously reduced, smooth muscle cell hyperplasia and elastic fibers were not seen.Conclusion: YSTZT can inhibit experimental hyperlipemia and atherogenesis. It is an ideal and effective medicine in preventing and treating hyperlipemia and atherosclerosis.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2001年第1期43-47,共5页 中国结合医学杂志(英文版)
关键词 Yishou Tiaozhi tablet HYPERLIPEMIA ATHEROSCLEROSIS Yishou Tiaozhi tablet, hyperlipemia, atherosclerosis
  • 相关文献

参考文献10

  • 1[1]XU SY. Screening method on lowering lipid drug and inhibiting arteriosclerosis drug. Pharmacological Experimental Methodology. Beijing: The People's Health Publishing House, 1985∶781-783.
  • 2[2]LI YL. Assay of alkali hydrolytic decomposition method on serum HYP determination. Clinical Journal of Decimology 1988;6(2)∶69-71.
  • 3[3]LI ZJ, HAN CS, WANG JX. Practical Radioimmunology. Beijing: The Scientific Technological Archive Publishing House, 1989∶198-221.
  • 4[4]GAO YC. Effect of Yixing decoction on rats' serum lipid level in hyperlipidemia and its mechanism. Academic Journal of Traditional Chinese Medicine 1990;(5)∶53-56.
  • 5[5]Manninen V, Tenkanen L. Lipid alteration and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988;260∶641-651.
  • 6[6]HUANG JG, translated. The atherosclerous lipid marker. Fascicle of Cardiovascular Disease in Journal of Foreign Medicine 1987;14(1)∶4-9.
  • 7[7]YANG RX. Lp(a) and atherosclerosis. Journal of Progression on Cardiovascular Disease 1994;15(4)∶221-223.
  • 8[8]Colin J, Schwartz MD. A modern view of atherogenesis. Am J Cardio 1993;71∶9B-14B.
  • 9[9]LIN XQ. Exploration on relationship between HYP and atherosclerosis in hyperlipidemia. Journal of Chinese Circulation 1993;8(3)∶160-163.
  • 10[10].CHEN SH. Hyperlipidemia and platelet high response. Fascicle of Cardiovascular Disease in Journal of Foreign Medicine 1989;16(5)∶257-262.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部